help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kannisto, S.
Right arrow Articles by Voutilainen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kannisto, S.
Right arrow Articles by Voutilainen, R.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 2 652-657
Copyright © 2000 by The Endocrine Society

Original Studies

Adrenal Suppression, Evaluated by a Low Dose Adrenocorticotropin Test, and Growth in Asthmatic Children Treated with Inhaled Steroids1

Senja Kannisto, Matti Korppi, Kyllikki Remes and Raimo Voutilainen

Department of Pediatrics, Kuopio University Hospital, FIN-70211 Kuopio, Finland

Address all correspondence and requests for reprints to: Senja Kannisto, M.D., Department of Pediatrics, Kuopio University Hospital, P.O. Box 1777, FIN-70211, Kuopio, Finland.

The aim of the present study was to evaluate the prevalence of adrenal suppression and growth retardation in children using moderate doses of budesonide or fluticasone propionate. Seventy-five asthmatic children were randomly divided into three treatment groups: 30 to the fluticasone propionate (FP), 30 to the budesonide (BUD), and 15 to the cromone (CROM) group. FP doses were 500 µg/day during the first 2 months and 200 µg/day thereafter. The respective BUD doses were 800 and 400 µg/day. A low dose ACTH (0.5 µg/1.73 m2) test was performed before treatment and 2, 4, and 6 months later. The test was considered abnormal if the stimulated serum cortisol concentration was more than 2 SD lower than the pretreatment mean (<330 nmol/L).

The low dose ACTH test was abnormal after both the high and low steroid doses in 23% of the children. At the 4 month measurement there were more abnormal tests in the BUD (n = 9) than in the FP (n = 5) group (P < 0.05). At that time also the stimulated concentration of serum cortisol was lower in the BUD than in the CROM group (P < 0.01), whereas the difference between the FP and CROM groups was not significant. During the study year the mean decrease in height SD score was 0.23 in the children treated with BUD, 0.03 in the children treated with FP, and 0.09 in the children treated with CROM; the difference between the BUD and FP groups was significant (P < 0.05).

In conclusion, the low dose ACTH test revealed mild adrenal suppression in a quarter of the children using moderate doses of inhaled steroids. A FP dose of 200 µg/day caused less adrenal and growth suppression than did a BUD dose of 400 µg/day.




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
J Paton, E Jardine, E McNeill, S Beaton, P Galloway, D Young, and M Donaldson
Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone
Arch. Dis. Child., October 1, 2006; 91(10): 808 - 813.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
A. Tirosh, D. Mandel, F. B. Mimouni, E. Zimlichman, T. Shochat, and I. Kochba
Autoimmune diseases in asthma.
Ann Intern Med, June 20, 2006; 144(12): 877 - 883.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. N. Priftis, A. Papadimitriou, E. Gatsopoulou, P. K. Yiallouros, A. Fretzayas, and P. Nicolaidou
The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children
Eur. Respir. J., February 1, 2006; 27(2): 316 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Masoli, M Weatherall, S Holt, and R Beasley
Systematic review of the dose-response relation of inhaled fluticasone propionate
Arch. Dis. Child., October 1, 2004; 89(10): 902 - 907.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
K A Dunlop, D J Carson, H J Steen, V McGovern, J McNaboe, and M D Shields
Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression
Arch. Dis. Child., August 1, 2004; 89(8): 713 - 716.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. B. Bacharier, H. H. Raissy, L. Wilson, B. McWilliams, R. C. Strunk, and H. W. Kelly
Long-Term Effect of Budesonide on Hypothalamic-Pituitary-Adrenal Axis Function in Children With Mild to Moderate Asthma
Pediatrics, June 1, 2004; 113(6): 1693 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. Roux, S. Kolta, J.-L. Desfougeres, P. Minini, and E. Bidat
Long-Term Safety of Fluticasone Propionate and Nedocromil Sodium on Bone in Children With Asthma
Pediatrics, June 1, 2003; 111(6): e706 - 713.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Sim, A. Griffiths, D. Armstrong, C. Clarke, C. Rodda, and N. Freezer
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
Eur. Respir. J., April 1, 2003; 21(4): 633 - 636.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
L Pescollderungg, G Radetti, E Gottardi, D G Peroni, A Pietrobelli, and A L Boner
Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test
Thorax, March 1, 2003; 58(3): 227 - 230.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Vermeer, B. I. Hendriks-Stegeman, B. van der Burg, S. C. van Buul-Offers, and M. Jansen
Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
G Russell
Inhaled corticosteroids and adrenal insufficiency
Arch. Dis. Child., December 1, 2002; 87(6): 455 - 456.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. E. Marik and G. P. Zaloga
Adrenal Insufficiency in the Critically Ill: A New Look at an Old Problem
Chest, November 1, 2002; 122(5): 1784 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Raivio, J. J. Palvimo, S. Kannisto, R. Voutilainen, and O. A. Janne
Transactivation Assay for Determination of Glucocorticoid Bioactivity in Human Serum
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3740 - 3744.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Skov, K.M. Main, I.B. Sillesen, J. Muller, C. Koch, and S. Lanng
Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide
Eur. Respir. J., July 1, 2002; 20(1): 127 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Price, P. Hindmarsh, S. Hughes, and J. Efthimiou
Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?
Eur. Respir. J., June 1, 2002; 19(6): 1179 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kannisto, M. Korppi, K. Remes, and R. Voutilainen
Serum Dehydroepiandrosterone Sulfate Concentration as an Indicator of Adrenocortical Suppression in Asthmatic Children Treated with Inhaled Steroids
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4908 - 4912.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society